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Clarifying the absence of evidence regarding human health risks to microplastic particles in 
drinking-water: High quality robust data wanted 
In a recently published article, Leslie and Depledge (2020) raise 
concerns regarding statements on the risk that microplastic particles 
represent to human health and which have been attributed to reports 
published by both the Science Academies’ Group, Science Advice for 
Policy (SAPEA) (part of the European Commission’s Science Advice 
Mechanism) and the World Health Organization (WHO) (SAPEA, 2019; 
WHO, 2019). Leslie and Depledge (2020), for instance, suggest that 
WHO (2019) conclude that there is ‘no evidence to indicate a human 
health concern.’ This statement, taken out of context from the WHO 
report (WHO, 2019), is then used to imply that the WHO conclude there 
is ‘no risk’ related to the exposure of microplastic particles (Leslie and 
Depledge, 2020). While, Leslie and Depledge (2020) highlight the 
importance of debate and systematic assessment of claims related to the 
assessment of risk, observations that we agree are important to high-
light, there are a number of points raised in the article that require 
clarification. 
Specifically and most importantly, the WHO report (WHO, 2019) 
does not conclude that microplastics are safe. The report (WHO, 2019), 
however, does acknowledge that there are significant uncertainties 
related to the quality and breadth of available data pertaining to human 
exposure to microplastics in drinking-water and that our knowledge 
regarding both exposure and toxicological effects require the acquisition 
of more robust ‘evidence’. In an effort to help strengthen the quality and 
robustness of data needed to better inform human health risk assess-
ment, the WHO report (WHO, 2019) identifies several research prior-
ities, which are further supported by an evaluation and guidance 
towards improving the characterization and quantification of micro-
plastic particles in drinking-water (Koelmans et al., 2019). 
The suggestion by Leslie and Depledge (2020) “…that it is clearly 
perilous to believe that the absence of evidence of risk translates into 
evidence for the absence of risk”, raises an important issue that policy 
makers must continuously address when considering policy decisions. 
To address the associated uncertainties in relation to the actual and 
potential risks attributed to exposure to microplastic particles there 
exists the following dilemma, which we perceive represents a source of 
frustration, not only to the research community as expressed by Leslie 
and Depledge (2020) but also to risk assessors, managers and decision 
makers:  
• The ‘evidence’ we have is not always the ‘evidence’ we want.  
• The ‘evidence’ we want is not always the ‘evidence’ we need.  
• The ‘evidence’ we need is not always the ‘evidence’ we can obtain.  
• The ‘evidence’ we can obtain costs more than we want to pay. 
Consequently, to obtain the appropriate ‘evidence’ associated with 
high-quality data and address the uncertainties requires resource, i.e. 
money, people, time. Furthermore, the suggestion that simply because 
the available ‘evidence’ is insufficient to demonstrate a risk to human 
health, is not the same to concluding that there is an absence of risk 
(Wardman et al., 2020). The fundamental basis of risk pertains to an 
assessment of probabilities, such as the probability of an adverse effect 
resulting from a probability associated with a potential exposure. From a 
probabilistic perspective, therefore, there always exists the probability 
of a risk – there is never a complete absence of risk – however, charac-
terizing and quantifying the associated probabilities is often challenging 
and complex. The objective of scientific research in helping to inform 
the assessment of risk is to test various hypotheses and to develop a 
weight-of-evidence that either supports or rejects the null hypothesis 
(Wardman et al., 2020). In the instance of human health effects asso-
ciated with exposure to microplastic particles in drinking-water, the 
evaluation of the current state-of-the science implies low probability of 
risk, although the report notes that the available information is insuf-
ficient to draw firm conclusions (WHO, 2019). Therefore a key message 
of the WHO report (WHO, 2019) is that there are significant un-
certainties related to the available data and that our knowledge 
regarding both exposure and toxicological effects require the acquisition 
of high quality robust ‘evidence’. In other words high quality robust data 
are needed and wanted to progress a meaningful assessment of human 
health risk 
How to best address the uncertainties and relative quality of the data, 
however, should consider the reality that we live in a world of limited 
resources. Consequently, opportunities to advise and prioritize re-
sources to help reduce key uncertainties are important to optimize, with 
the organization, development and publication of the WHO report 
(WHO, 2019) aimed at supporting the prioritization of research efforts. 
As noted by Leslie and Depledge (2020), ‘stakeholders including scien-
tists should thoughtfully and systematically scrutinize all claims, policy 
justifications and political angles in the debate. Multiple hypotheses and 
viewpoints abound and so they should until new data and better 
knowledge emerge.’ We entirely agree with this perspective and the 
WHO report (Leslie and Depledge, 2020) included efforts to address 
these very challenges – by including expert scientists from varying fields 
of expertise and perspectives in both the development and review of the 
report. Consequently, the conclusions and recommendations for future 
research were identified based on consensus from scientific experts from 
varying perspectives. 
It thus follows that based on the assessment of the available data, 
which imply that exposure concentrations do not currently represent 
significant risks to humans or the environment (SAPEA, 2019; WHO, 
2019) it would be inappropriate to suggest that drinking-water suppliers 
and regulators expend scarce resources to routinely monitor micro-
plastics, particularly when those resources could be directed towards 
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monitoring critical water quality parameters, of known public health 
significance, especially in low-income settings. The WHO report (WHO, 
2019), however, does emphasize the importance of putting in place and 
optimizing drinking-water and wastewater treatment systems, which 
are designed to remove particulates (and other contaminants including 
microbial pathogens) and therefore the implementation of these treat-
ment systems will reduce plastic particle concentrations (WHO, 2019). 
Encouraging the optimization of drinking-water and wastewater treat-
ment systems represents a key priority identified in the WHO report 
(WHO, 2019), a suggestion that is further augmented by a number of 
research recommendations. The WHO report (WHO, 2019), for instance, 
concludes that ‘to better assess human health risks and inform man-
agement actions, a number of research gaps need to be filled.’ Specific 
examples identified include:  
• The need to better understand microplastics occurrence throughout 
the water supply chain, using quality-assured methods to determine 
the numbers, sizes, composition and sources of microplastics and to 
better characterize the effectiveness of water treatment.  
• The development and application of quality-assured toxicological 
data on the most common forms of plastic particles relevant to 
human health risk assessment.  
• Improved understanding of the uptake and fate of both micro- and 
nano-plastic (<1 μm) following ingestion.  
• More robust data on exposure to both micro- and nano-plastic (<1 
μm) from all exposure pathways, including inhalation, food and 
beverages and an overall better assessment of exposure to micro-
plastics from the broader environment. 
Leslie and Depledge (2020) additionally note that the ability of 
microplastics to be chemical and pathogen vectors needs to be seriously 
considered. The WHO report (WHO, 2019) does indeed seriously 
address each of these issues in two sections of the report. One section on– 
“Possible human health risks associated with microplastics in drinking- 
water: particles and chemicals” and a second on “Possible human health 
risks associated with microplastics in drinking-water: biofilms”. The 
WHO report (WHO, 2019) indicates low concern for human health, 
which based on a conservative approach, inter alia, to assess the po-
tential for microplastics to act as vectors of chemicals. Statements that 
are further augmented with an acknowledgement that uncertainties in 
the exposure assessment represent important knowledge gaps that need 
to be considered. Consequently, the research needs identified in the 
WHO report (WHO, 2019) are perceived as important contributions 
towards directing future research activities, effectively and efficiently. 
Overall, the WHO, in its drinking water report, is strongly supportive 
of efforts that will help to reduce plastic pollution, which represents a 
central message of its press release that accompanied the report and 
statements on the WHO website. As noted in the WHO report, reducing 
sources of plastic pollution and of microplastics are win-win – these 
actions are better for the environment, for personal well-being, and as 
such it is a no-regrets intervention. The report also indicates that miti-
gating releases of plastic pollution and microplastics are key to helping 
to reduce human exposure. Activities of the WHO continuously take into 
account new science and recommendations from the 2019 report (WHO, 
2019) can be revised as new scientific understanding advances our un-
derstanding. Future research should ideally be targeted at priorities 
identified based on consensus from scientific experts from varying 
perspectives, such as from SAPEA (2019) and WHO (2019). Given WHO 
identified several research priorities in its 2019 report (WHO, 2019), it is 
not clear how this report should result in inaction by policy makers and 
researchers, as indicated by the Leslie and Depledge (2020) article. 
WHO is currently reviewing the state-of-science on the potential human 
health impacts of microplastics from the wider environment. This report 
will include an updated analysis on drinking-water, incorporating evi-
dence emerging post the WHO 2019 report (WHO, 2019), and will 
continue to engage scientists from varying perspectives. 
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